Abstract:Background\r\nToll like receptor 7 (TLR7) has been implicated in the development of autoimmune diseases, but its role in the regulation of T helper cell 17 (Th17) response in experimental autoimmune uveitis (EAU) by dendritic cells (DCs) has not been revealed yet.\r\n\r\n\r\nObjective\r\nThis study was to investigate the effect of bone marrow-derived dendritic cells (BMDCs) treated by TLR7 agonist CL097 on the regulation of interphotoreceptor retinoid-binding protein (IRBP)1-20-specific Th17 cells response in EAU.\r\n\r\n\r\nMethods\r\nBMDCs were isolated and collected from femur and tibia of naive C57BL/6 mice and cultured with recombinant mouse granulocyte-macrophage colony-stimulating factor (rmGM-CSF) and recombinant mouse interleukin-4 (rmIL-4). After cultured for six days, 5 μg/ml CL097 was added into the medium for 8 hours in the CL097 treated group, and PBS was used in the control group. Real-time fluorescence quantitative PCR (RT-qPCR) was employed to detect the relative expressions of IL-6, IL-23, IL-1β and transforming growth factor-β (TGF-β) mRNA in BMDCs. These mice received 1 μg of Bordetella pertussis toxin intra-peritoneally on the day of immunization, C57BL/6 mice were immunized with IRBP1-20 in complete Freund adjuvant containing heat-killed mycobacterium tuberculosis H37RA after two hours, EAU was evaluated by fundus examination on a scale of 0-4 reported by Caspi. Eyes harvested at 13 days after active immunization were processed for histopathological examination and stained with hemotoxylin and eosin. IRBP1-20-specific T cells were isolated from spleen cells and lymph node cells on the thirteenth day after immunization and co-cultured with CL097 treated or untreated BMDCs. After co-cultured for 5 days, cells were collected. Then, the relative expressions of IL-17, interferon-γ (IFN-γ), retinoic acid-related orphan receptor-γt (RORγt), T-box 21 transcription factor (T-bet) mRNA expression in T cells were tested by RT-qPCR. Percentages of Th1 cells and Th17 cells were assessed by flow cytometry. The results were compared between the two groups by independent sample t test.\r\n\r\n\r\nResults\r\nEAU model was successfully established. Compared with the control group, the expressions of IL-6, IL-23, IL-1β mRNA in BMDCs were significantly much higher, but the expression of TGF-β was much lower in the CL097 treated group than those in the control group (t=4.560, P=0.045; t=5.476, P=0.032; t=17.240, P=0.003; t=10.410, P=0.009). After IRBP1-20-specific T cells co-cultured with CL097-treated BMDCs, the expressions of RORγt mRNA and IL-17 mRNA were significantly higher than those of the control group (t=8.844, P=0.012; t=8.831, P=0.013), but no significant differences were seen in the expressions of T-bet mRNA and IFN-γ mRNA between the CL097 treated group and the control group (t=2.078, P=0.173; t=1.082, P=0.393). The flow cytometry revealed that the average percentages of Th17 cells were (17.750±4.793)% in the CL097 treated group and (10.240±3.173)% in the control group, showing a significant difference between them (t=4.938, P=0.039); while the average percentages of Th1 cells were not significantly different between the two groups ([1.123±0.356]% versus [1.060±0.384]%)(t=2.714, P=0.113).\r\n\r\n\r\nConclusions\r\nTLR7 agonist CL097 can stimulate BMDCs to secrete Th17-polarizing cytokines and promote the differentiation of Th17 cells.\r\n\r\n\r\nKey words: \r\nToll-like receptor 7/agonist, CL097; Uveitis/immunology; CD4-positive T-lymphocytes/secretion; T helper cell 17; Cell polarity/immunology; Inflammation mediators; Dendritic cells/bone marrow-derived; C57BL/6 mouse

TLR7 Engagement on Dendritic Cells Enhances Autoreactive Th17 Responses Via Activation of ERK.

Engagement of Toll-like Receptor 2 Enhances Interleukin (IL)-17(+) Autoreactive T Cell Responses Via P38 Mitogen-Activated Protein Kinase Signalling in Dendritic Cells.

Enhancement effect of TLR7 agonist CL097 on the activity of Th17 cells in experimental autoimmune uveitis

Inhibiting TLR7 Expression in the Retinal Pigment Epithelium Suppresses Experimental Autoimmune Uveitis

Treatment of Autoimmune Inflammation by a TLR7 Ligand Regulating the Innate Immune System

Mettl3 Induced Mir-338-3p Expression in Dendritic Cells Promotes Antigen-Specific Th17 Cell Response Via Regulation of Dusp16.

In Vivo Priming of IL-17(+) Uveitogenic T Cells is Enhanced by Toll Ligand Receptor (TLR)2 and TLR4 Agonists Via Γδ T Cell Activation.

Rkip Mediates Autoimmune Inflammation By Positively Regulating Il-17r Signaling

Toll Like Receptors Signaling Pathways Directly Increase the Expression of Functional IL-17RA in Neu-Roglial Cells

Regulatory Effect of Gammadelta T Cells on IL-17+ Uveitogenic T Cells.

TLR Agonists Promote ERK-mediated Preferential IL-10 Production of Regulatory Dendritic Cells (diffdcs), Leading to NK-cell Activation

Toll-like Receptor Signaling Directly Increases Functional IL-17RA Expression in Neuroglial Cells.

Natural Compound 2,2′,4′-Trihydroxychalcone Suppresses T Helper 17 Cell Differentiation and Disease Progression by Inhibiting Retinoid-Related Orphan Receptor Gamma T

TPL2 Mediates Autoimmune Inflammation Through Activation of the TAK1 Axis of IL-17 Signaling

TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function

BRAF-V600E Utilizes Posttranscriptional Mechanisms to Amplify LPS-induced TNFα Production in Dendritic Cells in a Mouse Model of Langerhans Cell Histiocytosis.

TCR Signaling Induces STAT3 Phosphorylation to Promote TH17 Cell Differentiation.

Role of CD25+ dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis

Nk-Dc Crosstalk Controls The Autopathogenic Th17 Response Through An Innate Ifn-Gamma-Il-27 Axis

REGγ controls Th17 cell differentiation and autoimmune inflammation by regulating dendritic cells

Threonyl-tRNA Synthetase Promotes T Helper Type 1 Cell Responses by Inducing Dendritic Cell Maturation and IL-12 Production via an NF-κB Pathway